Novavax, Inc. (LON:0A3S)
6.42
-0.06 (-0.93%)
At close: Jun 27, 2025
Novavax Market Cap
Novavax has a market cap or net worth of 752.34 million as of June 30, 2025. Its market cap has decreased by -59.24% in one year.
Market Cap
752.34M
Enterprise Value
385.69M
Revenue
971.33M
Ranking
n/a
PE Ratio
2.03
Stock Price
6.42
Market Cap Chart
Since July 25, 1996, Novavax's market cap has increased from 22.60M to 752.34M, an increase of 3,228.98%. That is a compound annual growth rate of 12.88%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 158.54B |
Shell | 158.05B |
HSBC Holdings | 151.89B |
Unilever | 115.05B |
British American Tobacco p.l.c. | 75.07B |
Rolls-Royce Holdings | 74.43B |
Rio Tinto Group | 72.20B |
RELX PLC | 72.14B |